Watanabe Todd Franklin's Form 4 filing
Arcutis Biotherapeutics, Inc. (ARQT) · filed Aug 5, 2026
- Accession no.
- 0001628280-26-053753
- Filed
- Aug 5, 2026, 9:42 PM ET
- Trade date
- Aug 3, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $114.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Watanabe Todd FranklinCIK 0001801061 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Common Stock | SSaleDisposed | −4,375 | $26.12 | −$114,261 | 717,203 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.